Limin Liu
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Unveiling a J-shaped association between the triglyceride-glucose index and in-hospital major adverse cardiovascular events in patients with acute myocardial infarction: a retrospective cohort study of 1,065 patients.
Journal: Frontiers in cardiovascular medicine
Published: March 14, 2026
Dabigatran-based versus warfarin-based triple antithrombotic regimen with a 1-month intensification after coronary stenting in patients with nonvalvular atrial fibrillation (COACH-AF PCI).
Journal: BMC medicine
Published: February 13, 2025
Assessment of postoperative prognosis in patients with acute ST-segment elevation myocardial infarction after PCI using LRP1.
Journal: Frontiers in cardiovascular medicine
Published: October 31, 2024
Construction and validation of coronary heart disease risk prediction model for general hospitals in Tacheng Prefecture, Xinjiang, China.
Journal: Frontiers in cardiovascular medicine
Published: October 20, 2024
The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling.
Journal: European journal of pharmacology
Published: July 02, 2023
Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.
Journal: Lancet (London, England)
Published: October 02, 2022
Fatty acid binding protein 3 deficiency limits atherosclerosis development via macrophage foam cell formation inhibition.
Journal: Experimental cell research
Published: June 04, 2021
miR-145-5p attenuates inflammatory response and apoptosis in myocardial ischemia-reperfusion injury by inhibiting (NADPH) oxidase homolog 1.
Journal: Experimental animals
Published: March 04, 2021
Long non‑coding RNA MALAT1 regulates cholesterol accumulation in ox‑LDL‑induced macrophages via the microRNA‑17‑5p/ABCA1 axis.
Journal: Molecular medicine reports
Published: July 04, 2019
Inhibition of microRNA-17-5p reduces the inflammation and lipid accumulation, and up-regulates ATP-binding cassette transporterA1 in atherosclerosis.
Journal: Journal of pharmacological sciences
Published: August 23, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026